Details on surprise Novartis heart drug success due Aug 27

LONDON (Reuters) - Full details on the surprise success of a Novartis anti-inflammatory drug in cutting cardiovascular risk for heart attack survivors will be presented at a medical meeting on Aug. 27, conference organizers said on Thursday.